Journal of Immunology Research · 2020 · 12 citations · 44 references
MedicineNephrologyPharmacologyInflammationMolecular PharmacologyRenal PathophysiologyAcute InflammationAcute Kidney InjuryNeuroprotectionRenal IschemiaRenal Ischemic InjuryRenal PharmacologyAnti-inflammatory ActivityIschemic Acute Kidney InjuryNf-κb SignalingNuclear Factor Kappa B ActivationNuclear Factor Kappa B ModulationNuclear Factor Kappa B SignalingPreconditioningRenoprotective Effects
Acute kidney injury (AKI) is one of the most common and troublesome perioperative complications. Dexmedetomidine (DEX) is a potent α 2‐adrenoceptor ( α 2‐AR) agonist with anti‐inflammatory and renoprotective effects. In this study, a rat renal ischemia–reperfusion injury (IRI) model was induced. At 24 h after reperfusion, the IRI‐induced damage and the renoprotection of DEX preconditioning were confirmed both biochemically and histologically. Changes in nuclear factor‐kappa B (NF‐ κ B), as well as its downstream anti‐inflammatory factor A20 and proinflammatory factor tumor necrosis factor‐ α (TNF‐ α ), were detected. Atipamezole, a nonselective antagonist, was then added 5 min before the administration of DEX to further analyze DEX’s effects on NF‐ κ B, and another anti‐inflammatory medicine, methylprednisolone, was used in comparison with DEX, to further analyze DEX’s effects on NF‐ κ B. Different concentrations of DEX (0 nM, 0.1 nM, 1 nM, 10 nM, 100 nM, 1 μ M, and 10 μ M) were applied to preincubated human renal tubular epithelial cell line (HK‐2) cells in vitro. After anoxia and reoxygenation, the MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) tetrazolium assay and enzyme‐linked immunosorbent assay (ELISA) were performed to evaluate the levels of NF‐ κ B downstream anti‐inflammatory cytokines. The results showed that, unlike methylprednisolone, DEX preconditioning led to a time‐dependent biphasic change (first activation then inhibition) of NF‐ κ B in the rat renal IRI models that were given 25 μ g/kg i.p. It was accompanied by a similarly biphasic change of TNF‐ α and an early and persistent upregulation of A20. In vitro, DEX’s cellular protection showed a concentration‐dependent biphasic change which was protective within the range of 0 to 100 nM but became opposite when concentrations are greater than 1 μ M. The changes in the A20 and NF‐ κ B messenger RNA (mRNA) levels were consistent with the renoprotective ability of DEX. In other words, DEX preconditioning protected the rats from renal IRI via regulation biphasic change of NF‐ κ B signaling.
44
Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression
David E. Nelson, Adaoha Ihekwaba, Malcolm C. Elliott et al. · Science · 2004 · 1.2K citations
Possible new role for NF-κB in the resolution of inflammation
Toby Lawrence, Derek W. Gilroy, Paul Colville‐Nash et al. · Nature Medicine · 2001 · 747 citations